Target intelligence / Profile preview

Histone H2B type 1-B (H2BC3)

Target
H2BC3
Molecular classification
Histone, Other (Structural chromatin protein)
01

Overview

Histone H2B type 1-B (H2BC3) is a core component of the nucleosome, the fundamental unit of chromatin in eukaryotic cells. It is a basic nuclear protein that, together with other histone proteins (H2A, H3, and H4), forms the nucleosome octamer around which DNA is wrapped, enabling condensation and organization of DNA within the nucleus. H2BC3 is involved in essential biological processes such as transcription regulation, DNA replication, DNA repair, and maintenance of chromosomal stability. Post-translational modifications of H2BC3, such as acetylation, phosphorylation, and ubiquitination, play a central role in regulating chromatin structure and gene expression. Variants and modifications of H2B are implicated in processes including the DNA damage response and regulation of active transcription, while alterations or mutations in histones have been associated with diseases such as cancer and certain genetic syndromes[1][2][5]. No approved or investigational drugs currently target H2BC3 directly, and it is generally not considered a therapeutic target due to its essential and ubiquitous structural role in all nucleated cells[1][2][5].

Other names
H2B clustered histone 3H2BC3H2BFFHIST1H2BBH2B/fHistone H2B.1Histone H2B.fH2B.1histone cluster 1 H2B family member bH2B histone family, member FH2bb
02

Biological functions

Chromatin organizationDNA packagingRegulation of transcriptionDNA repairDNA replicationChromosomal stability
03

Disease associations

CancerCockayne syndromeOther (developmental and chromatin-related disorders)
04

Safety considerations

Targeting core histones may cause global effects on chromatin and gene expressionEssential for cell viability; depletion or inhibition is toxic

Beyond the preview

Go deeper on Histone H2B type 1-B (H2BC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2B type 1-B (H2BC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call